re: Axon - Its all to do with the accounting treatment.
They wrote off R&D of $7M in the first 6 months consistent with prior periods.
They could have equally reported a $2M profit for the period.
I find it funny that firms which have conservative accounting policies get hammered in times of uncertainty.
Also note that AXON has no debt.
The real story with AXON begins this month with the release of their mass market products.
